Ironwood Pharmaceuticals | IRWD - 営業経費





営業経費 変化する 日付
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Almirall EUR 517.4M 32K 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
Astellas Pharma JPY 436.66B 16.75B 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Coherus Biosciences USD 51.83M 2.48M 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
MacroGenics USD 53.32M 13.68M 2025-12
Moderna USD 1.54B 259M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Pacira USD 193.68M 27.32M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Takeda JPY 1.02T 400.98B 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vanda Pharmaceuticals USD 466M 20.33M 2025-09